Real-World, Open-Label Study of the Efficacy and Safety of a Novel Serum in Androgenetic Alopecia
May 2023
in “
Journal of Drugs in Dermatology
”
Studysummary This study reported that the novel topical serum REVIVV®, containing a blend of phytochemicals, significantly improved hair growth and reduced shedding in 150 participants with androgenetic alopecia after 8 weeks of use, while also being rated easy to use and prompting plans for continued use.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on jddonline.com →